Placing on the market for the first time in France in 1981, this molecule has quickly gained acceptance among cattle meat (it is forbidden for females producing milk for human consumption) and horse owners: it uses a single product to treat many internal and external parasites, and this in a simple way: orally in horses and sheep, injection in cattle, sheep or pigs, or transcutaneous passage by applying the treatment on the back line in cows. Finally, it has a long action, which does not handle animals often.
Kuweka juu ya soko kwa mara ya kwanza katika Ufaransa katika 1981, molekuli hii ina haraka kupata kukubalika miongoni mwa nyama ng'ombe (ni haramu kwa wanawake kuzalisha maziwa kwa matumizi ya binadamu) na wamiliki farasi: inatumia bidhaa moja kwa kutibu vimelea wengi ndani na nje ya, na hii kwa njia rahisi: mdomo katika farasi na kondoo, sindano katika ng'ombe, kondoo au nguruwe, au kifungu Transcutaneous kwa kutumia matibabu kwenye mstari nyuma katika ng'ombe. Hatimaye, ina hatua kwa muda mrefu, ambayo haina kushughulikia wanyama mara nyingi.